Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
01/2011
01/13/2011US20110009623 Selective growth of stable polymorphs
01/13/2011US20110009456 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
01/13/2011US20110009448 Compound
01/13/2011US20110009428 Novel androgens
01/13/2011US20110009379 Indolinone compound
01/13/2011US20110009371 Synthesis of tetracyclines and analogues thereof
01/13/2011US20110008373 Prodrugs of cc-1065 analogs
01/13/2011US20110005596 Dye for dye-sensitized solar cell and dye-sensitized solar cell including the same
01/13/2011CA2767132A1 Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-l1-indole-1-acetic acid
01/12/2011EP2272828A1 Compound for organic electroluminescent device and organic electroluminescent device using the same
01/12/2011EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011EP2271618A1 Pharmaceutical compounds
01/12/2011EP2271617A1 Substituted 4-hydroxy-n- (4-hydroxyphenyl) indoles as estrogenic agents
01/12/2011EP2271613A1 Hydroxymethylcyclohexyl amines
01/12/2011EP1682138B1 Heterocyclic inhibitors of mek
01/12/2011CN1856313B Therapeutic compounds
01/12/2011CN101945859A Bis-(sulfonylamino) derivatives in therapy
01/12/2011CN101941939A Polyfunctional carbazole derivative oxime ester compound and preparation method and light polymerization initiator thereof
01/12/2011CN101941938A Tryptophan chelate and preparation method and application thereof
01/12/2011CN101941937A Method for concentrating 5-hydroxytrophan
01/12/2011CN101941936A Process for extracting 5-hydroxytryptamine as bioactive substance from sea buckthorns
01/12/2011CN101941920A Aromatic ketone oxime photoinitiator compound
01/12/2011CN101010276B Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
01/11/2011US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia
01/11/2011US7868187 Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes
01/11/2011US7868186 organic thin film transistor with a semiconductor layer including the polymer of 2,8-Bis(2-thienyl)-5,11-didodecylindolo[3,2-b]carbazole; organic photovoltaics
01/11/2011US7868157 low non-specific binding, photostable, ease of chemical modification to permit tuning of absorption and emission wavelengths and resistance to the formation of dimers; 1-(5-carboxy-pentyl)-2-[5-(1-ethyl-3,3-dimethyl-5-phosphono-1,3-dihydro-indol-2-ylidene)-penta-1,3-dienyl]-3,3-dimethyl-3H-indolium
01/11/2011US7868037 comprising administering compounds that affect viral internal ribosome entry site (IRES) activity, such as [4-(3-cyano-1-ethyl-6-methoxy-1H-indol-2-yl)-phenyl]-carbamic acid ethyl ester
01/11/2011US7868036 Renin inhibitors; hypertension, heart failure, glaucoma, myocardial infarction, kidney failure or restenosis; broad group of compounds that are hydroxy-functional diamines such as 3-Amino-1-isopropylamino-5-[3-(3-methoxypropyl)-1-methyl-1H-indol-5-ylmethyl]-6-methylheptan-2-ol dihydrochloride
01/11/2011US7868034 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
01/11/2011US7868008 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
01/11/2011US7867631 N,N-bis((9-(4-fluorophenyl-)carbazol-3-yl-)phenylamine; good electrical properties; charge transport capability; fluorescence; phosphorescence; full spectrum of colors, including red, green, blue, and white; OLED/organic light eitters/; high efficiency; low voltage;brightness; durability
01/11/2011CA2487973C Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
01/11/2011CA2468824C Hexacyclic compounds
01/11/2011CA2451678C Azaindoles
01/11/2011CA2449555C Hydroxylation of beta-dicarbonyls with zirconium catalysts
01/11/2011CA2420592C Fused pyrrolocarbazoles against inflammation
01/11/2011CA2372063C Pyridopyranoazepine derivatives, their preparation and their therapeutic application
01/06/2011WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
01/06/2011WO2011002339A2 PHARMACEUTICALLY ACCEPTABLE SALTS OF (S)-N-[4-(1-ADAMANTYL)BENZOYL-α-AMINO ACIDS AND METHOD FOR THE PRODUCTION THEREOF
01/06/2011WO2011002103A2 A cycloalkane derivative
01/06/2011WO2011002076A1 Method for producing lactam compound and production intermediate thereof
01/06/2011WO2011002038A1 Novel diarylamine compound, and anti-aging agent, polymer composition, crosslinked rubber product and molded article thereof, and method for producing diarylamine compound
01/06/2011WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/06/2011WO2011000459A1 Continuous method for producing amides of aromatic carboxylic acids
01/06/2011WO2010129057A3 Tetracycline compounds
01/06/2011US20110004005 Rhodium-phosphorus complexes and their use in ring opening reactions
01/06/2011US20110004003 Compound, Photochromic Material, Electronic Material, Compound Producing Method, 2,3-BIS(N,N-BIS(P-ANISYL)4-Minophenylethynyl)Dimethylfumarate Producing Method and 2,3-BIS(N,N-BIS(P-ANISYL)4-Aminophenylethynyl)Dimethylmaleate Producing method
01/06/2011US20110003959 Coordination complex system comprising tautomeric ligands
01/06/2011US20110003955 Imide Oligomer And Polyimide Resin Obtained By Thermal Curing Thereof
01/06/2011US20110003878 Novel derivatives of phthalimide as histone deacetylase inhibitors
01/06/2011US20110003876 Tetrahydroindoles Having Sphingosine-1-Phosphate Receptor Activity
01/06/2011US20110003851 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
01/06/2011US20110003836 Pro-Neurogenic Compounds
01/06/2011US20110003011 Fungicidal active compound combinations
01/06/2011CA2766926A1 Continuous method for producing amides of aromatic carboxylic acids
01/06/2011CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/05/2011EP2270895A2 Complexes for OLEDs
01/05/2011EP2270106A2 Indolium compounds containing fluoro-substituents
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2270004A1 Caspase inhibitors and uses thereof
01/05/2011EP2268625A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
01/05/2011EP2268616A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
01/05/2011EP2268612A1 Arylsulfonamide-based matrix metalloprotease inhibitors
01/05/2011EP1881977B1 Histone deacetylase inhibitors
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011EP1147214B1 A novel method for designing protein kinase inhibitors
01/05/2011DE102009031021A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
01/05/2011CN101939296A Carbazole-containing materials in phosphorescent light emitting diodes
01/05/2011CN101935301A Modulators of ATP-binding cassette transporters
01/05/2011CN101935297A 3,3- diindolyl derivative and preparation method thereof
01/04/2011US7863462 Process for the purification of ropinirole hydrochloride
01/04/2011US7863315 enzyme inhibitors such as 2-(5-(((5-fluoro-2-oxoindolin-3- ylidene)hydrazono)methyl)-2,4-di- methyl-1H-pyrrole-3-carboxamido)- N-hydroxyacetamide, used for treating , fragile X syndrome, leukemia, cancer, cardiac hypertrophy, bone, immunological, nervous system, neurodegenerative and genetic disorders
01/04/2011US7863305 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors
01/04/2011US7862905 Arylamine compound and organic electroluminescent device
01/04/2011CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie
01/04/2011CA2488363C O-substituted hydroxyaryl derivatives
01/04/2011CA2375008C Phenoxypropylamine compounds
01/04/2011CA2319672C Compounds and compositions for delivering active agents
01/04/2011CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them
12/2010
12/30/2010US20100331540 Method for producing compound having deuterated aromatic ring or heterocyclic ring
12/30/2010US20100331441 Functionalization of organic surfaces
12/30/2010US20100331383 Compounds for the treatment of aids and other viral diseases
12/30/2010US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100330245 Crystals of non-natural-type stereoisomer salt of monatin and use thereof
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100327269 Emissive triaryls
12/29/2010WO2010151541A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
12/29/2010WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/29/2010WO2010150988A2 Anthracene derivatives and organic electroluminescence device using same
12/29/2010WO2010150837A1 Indoline derivative
12/29/2010WO2010150206A1 N-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
12/29/2010WO2010113183A3 Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265583A1 Spiroindolinone derivatives
12/29/2010EP2265582A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof.
12/29/2010EP2265581A1 Compounds having crth2 antagonist activity
12/29/2010EP2185512B1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 458